title: Control of the blood-brain barrier function in cancer cell metastasis.
abstract: Cerebral metastases are the most common brain neoplasms seen clinically in the adults and comprise more than half of all brain tumours. Actual treatment options for brain metastases that include surgical resection, radiotherapy and chemotherapy are rarely curative, although palliative treatment improves survival and life quality of patients carrying brain-metastatic tumours. Chemotherapy in particular has also shown limited or no activity in brain metastasis of most tumour types. Many chemotherapeutic agents used systemically do not cross the blood-brain barrier (BBB), whereas others may transiently weaken the BBB and allow extravasation of tumour cells from the circulation into the brain parenchyma. Increasing evidence points out that the interaction between the BBB and tumour cells plays a key role for implantation and growth of brain metastases in the central nervous system. The BBB, as the tightest endothelial barrier, prevents both early detection and treatment by creating a privileged microenvironment. Therefore, as observed in several in vivo studies, precise targetting the BBB by a specific transient opening of the structure making it permeable for therapeutic compounds, might potentially help to overcome this difficult clinical problem. Moreover, a better understanding of the molecular features of the BBB, its interrelation with metastatic tumour cells and the elucidation of cellular mechanisms responsible for establishing cerebral metastasis must be clearly outlined in order to promote treatment modalities that particularly involve chemotherapy. This in turn would substantially expand the survival and quality of life of patients with brain metastasis, and potentially increase the remission rate. Therefore, the focus of this review is to summarise the current knowledge on the role and function of the BBB in cancer metastasis.
authors.affiliation: Department of Experimental Neurosurgery, Charité-Universitätsmedizin Berlin, Berlin, 10119, Germany.
authors.forename: Kinga G
authors.initials: KG
authors.lastname: Blecharz
authors.affiliation: Department of Neurosurgery, Göttingen University Medical Center, Göttingen, 37070, Germany.
authors.forename: Ruben
authors.initials: R
authors.lastname: Colla
authors.affiliation: Department of Neurosurgery, Göttingen University Medical Center, Göttingen, 37070, Germany.
authors.forename: Veit
authors.initials: V
authors.lastname: Rohde
authors.affiliation: Department of Experimental Neurosurgery, Charité-Universitätsmedizin Berlin, Berlin, 10119, Germany.|Department of Neurosurgery, Charité-Universitätsmedizin Berlin, Berlin, 13353, Germany.
authors.forename: Peter
authors.initials: P
authors.lastname: Vajkoczy
mesh_terms: D000818:Animals; D001812:Blood-Brain Barrier / Q000502:physiology*; D001932:Brain Neoplasms / Q000556:secondary*; D006801:Humans; D009361:Neoplasm Invasiveness / Q000473:pathology*
keywords: Angiogenesis; Blood-brain barrier; Endothelium; Metastasis; Permeability